Shionogi & Co. Ltd.

Company Overview

Shionogi and Co. Ltd. is a pharmaceutical organization primarily engaged in the advancement, research and purchase of pharmaceutical-related businesses and pharmaceutical sales. The company provides its services and products in Europe, Japan and North America. It owns more than 20 global subsidiaries. Shionogi reported sales revenue of $3.10 billion for the financial year 2021.

Shionogi has sales and supply operations in many countries. The company has more than 50 years of experience in anti-infective research, and it has altered the advancements of antiviral and antibacterial treatments. Shionogi’s key focus areas include the development of novel treatments such as pathogens, viruses and bacteria that cause numerous untreatable infections. The company’s vison and mission entail growing globally as a drug-discovery-based pharmaceutical company; it is also focusing on expanding sales of Osphena in the U.S to increase growth of the company in the Asia-Pacific region, Europe and the U.S.

Shionogi develops and manufactures pharmaceutical products to treat patients who commonly suffer from pain and infection diseases, as well as other areas of high therapeutic need, such as chronic liver disease. Shionogi’s medicine portfolio includes antibiotic medicines, hyperlipidaemia medicines and cancer medicines. The company also develops and manufactures medicines for the treatment of neuropathic pain, inflammatory pain, ADHD and Alzheimer’s disease. It has a wide portfolio of products, including Naldemedine, lusutrombopag, Claritin, Niitrazepam, Moxifloxacin, Osphena, Cymbalata, Baloxavir marboxil and Adapalene. Its products are used in the treatment of allergies, cardiovascular diseases, insomnia, disable anxiety, acne, bacterial infections, dyspareunia, neuropathic pain, flu and chronic liver diseases.

Financial Highlights (FY 2024)

Company's Business Segments

• Domestic Prescription Drugs : Infectious Disease Drugs, CYMBALTA, OXYCONTIN Franchise, SYMPROIC, ACTAIR, MULPLETA, PIRESPA, Others.
• Overseas Subsidiaries/ Exports : Shionogi Inc., Ping An-Shionogi / C&O, Shionogi B.V.
• Royalties : HIV Franchise Royalties, CRESTOR, Others.